Full-Time
Pharmacy Technician
BrightSpring Health Services
10,001+ employees
Home-based health services and pharmacy solutions
No salary listed
Horsham, PA, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to BrightSpring Health Services
See people who can refer or advise you
- A high school diploma or equivalent is required.
- A Pharmacy Technician license is required as required by the state.
- Experience in a pharmacy setting and knowledge of medical terminology are required.
- Ability to operate a computer and recognize and identify medications is required.
- The role requires attention to detail, goal orientation, teamwork, and effective oral communication.
- Fill prescription items and package medications for dispensing and delivery.
- Accurately label products, including cautionary and auxiliary labels.
- Prepare medications, including non-sterile compounding of liquids, powders, ointments, and similar preparations.
- Enter patient and prescription data into the computer system to generate labels.
- Participate in pharmacy inventory management, including checking stock and removing expired medications.
- Handle returned medications according to protocol, including credit or destruction.
- Communicate professionally with internal and external customers.
- Assist with onboarding and training new pharmacy staff.
- Work in the Controlled Drugs (Narcotics) Room.
- Operate automated machines to prepack medications.
- Mix intravenous medications and sanitize the intravenous room and equipment.
- Service facility-based dispensing machines such as RxNow.
- Perform other assigned pharmacy support tasks.
- Long-term care pharmacy experience.
BrightSpring Health Services delivers home and community-based health services for people with complex or chronic needs, organized into two segments: Pharmacy and Provider. The Pharmacy segment provides specialty, infusion, and community pharmacy services to patients with complex conditions. The Provider segment offers behavioral health, home health, hospice care, and services for individuals with intellectual and developmental disabilities. The company runs an integrated care model through a network of pharmacies and providers to support a continuum of care that includes clinical services, care coordination, and in-home support. Revenue comes from Medicare, Medicaid, and private insurance, reflecting reimbursement across public and private payers. The goal is to coordinate pharmacy and in-home health services to improve access, continuity, and outcomes for patients and to serve managed care organizations with a complete care solution.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Get referred to BrightSpring Health Services
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue reached $3.87 billion, up 23%, with EBITDA up 44%.
- March 30, 2026 Community Living sale cut leverage to 2.15x and funded buybacks.
- Amedisys and LHC branches added 107 assets, with 2026 EBITDA contribution guided to $35 million.
What critics are saying
- July 31, 2026 guidance still includes roughly $175 million Inflation Reduction Act headwinds.
- PharMerica's $5.275 million breach settlement highlights recurring cybersecurity and HIPAA exposure.
- Provider integration and reimbursement dependence create an existential squeeze if payers cut contracts.
What makes BrightSpring Health Services unique
- BrightSpring integrates specialty pharmacy and provider services across 50 states.
- Q2 2026 specialty and infusion revenue grew 30% on limited-distribution drug wins.
- The company combined pharmacy, home health, hospice, and IDD services under one platform.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -10%1 year growth
↓ -10%2 year growth
↓ -10%Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.
BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.
Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.
BrightSpring Health Services shares fell 17.5% after reporting second-quarter results, despite beating expectations. The healthcare services provider posted revenue of $3.87 billion, up 23% year-on-year, whilst non-GAAP profit reached $0.45 per share, exceeding forecasts. The company also raised its full-year guidance. However, investors responded negatively in what appeared to be a "sell-the-news" reaction. The sell-off may stem from valuation concerns and stagnant profit margins despite rising sales, raising questions about the company's cost structure. The stock has experienced 18 movements greater than 5% over the past year. At $59.71 per share, BrightSpring trades 18.1% below its 52-week high of $72.91 from July, though it remains up 55.5% year-to-date.
BrightSpring Health Services reported strong second-quarter 2026 results, with total revenue reaching $3.9 billion, up 23% year-over-year. Adjusted EBITDA rose 44% to $206 million, exceeding expectations. The company's Pharmacy Solutions segment drove growth, with specialty and infusion revenue climbing 30%. Provider Services revenue increased 30%, supported by robust home health care volume growth and successful integration of Amedisys and LHC branches, expected to contribute approximately $35 million in EBITDA for 2026. BrightSpring reduced leverage to 2.15 times as of 30 June and secured credit rating upgrades from S&P and Moody's. The company refinanced debt at 50 basis points lower spread. Management raised full-year 2026 adjusted EBITDA guidance to between $820 million and $845 million, representing 32.8% to 36.8% growth, with expected operating cash flow of approximately $600 million.